Dr. Johnson Preetham Britto, M.D. Internal Medicine - Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 651 Centre View Blvd, Crestview Hills, KY 41017 Phone: 859-757-4446 Fax: 859-344-1999 |
News Archive
Icon Bioscience, Inc., (IBI), a privately held biopharmaceutical company that specializes in the development and commercialization of novel ophthalmic pharmaceuticals announced today that it has initiated its Phase 2/3 pivotal clinical trial to assess the safety and efficacy of IBI-10090 in patients undergoing cataract surgery.
As municipalities have taxed sugar-sweetened beverages and schools and worksites have banned their sales, university researchers have found that simple warning labels on such beverages in a college cafeteria helped students reduce their reported consumption of drinks by 14.5 percent.
A team of researchers, led by physicians from Children's Hospital Los Angeles, have found that infants with bronchiolitis who were treated with inhaled hypertonic saline in the emergency department (ED) were less likely to require admission to the hospital compared to infants treated with normal saline.
Humacyte, Inc. and Xcellerex, Inc. have entered into an initial strategic collaboration for Xcellerex to develop a novel manufacturing process that will enable the production of Humacyte's lead regenerative medicine product using Xcellerex's XDR single use bioreactor system in its FlexFactory®. Humacyte's product is a large diameter vascular graft that is based on its innovative and proprietary platform technology for engineering human, extracellular matrix-based tissues that have properties that are similar to native tissues.
The humble tomato could be a suitable carrier for an oral vaccine against Alzheimer's disease, according to HyunSoon Kim from the Korea Research Institute of Bioscience and Biotechnology (KRIBB) in Korea and colleagues from Digital Biotech Inc. and the Department of Biological Science at Wonkwang University.
› Verified 7 days ago